HCPCS Level IIdrugActive
J9049
Inj, bortezomib, hospira
BETOS: O1D
Effective: 2023-01-01
Referenced in 1 policies
Description
Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Bortezomib
Manufacturer
Pfizer Inc
HCPCS Dosage
0.1 MG
Billing Units
25.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.